Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?

被引:23
|
作者
Kutluk, Gunsel [1 ]
Tutar, Engin [1 ]
Bayrak, Aykut [1 ]
Volkan, Burcu [1 ]
Akyon, Yakut [3 ]
Celikel, Cigdem [2 ]
Ertem, Deniz [1 ]
机构
[1] Marmara Univ Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, TR-34854 Istanbul, Turkey
[2] Marmara Univ Sch Med, Dept Pathol, TR-34854 Istanbul, Turkey
[3] Hacettepe Univ Sch Med, Dept Microbiol, Ankara, Turkey
关键词
antibiotic resistance; children; Helicobacter pylori; sequential; standard; treatment; ANTIBIOTIC-RESISTANCE; RANDOMIZED-TRIAL; CONSENSUS REPORT; INFECTION; METAANALYSIS; MANAGEMENT; GENOTYPES; REGIMEN; SPECIMENS; TRENDS;
D O I
10.1097/MEG.0000000000000190
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective There has been a marked decrease in the eradication rates of Helicobacter pylori infection with standard triple therapy worldwide. Hence, sequential therapy has gained attention as a promising treatment during the last few years. This study was carried out to compare the efficacy of sequential versus standard triple therapy in the context of clarithromycin (CLA) resistance. Materials and methods In this study, children between 3 and 18 years of age, who had documented H. pylori infection, were randomized to receive either standard triple or sequential therapy. H. pylori eradication was ascertained using the C-13-urea breath test 4-6 weeks after the completion of the treatment. Real-time PCR was performed on gastric biopsy samples for assessment of CLA resistance. Results In all, 148 children (median age: 12.18 +/- 3.51 years) were recruited randomly into the study. The intention-to-treat eradication rates were 50% (37/74) for the sequential treatment group and 52.7% (39/74) for the standard triple treatment group (P = 0.87). A total of 136 children completed the study. The per-protocol eradication rates were 56% (37/66) and 55.7% (39/70) for sequential and standard triple therapy groups, respectively. CLA resistance was assessed and 113 children were included in the final analysis. Of 113 participants, 53 were in the sequential treatment group and 60 were in the standard triple treatment group. The success rates of the respective therapies (29/53 = 54.7% in sequential, 33/60 = 55% in standard therapy) were similar (P = 0.98). CLA resistance was detected in 29 (25.7%) of the patients. Eradication rates with sequential therapy in CLA susceptible and resistant cases were 60.5% (23/38) and 40% (6/15), respectively (P = 0.23). The corresponding figures for the standard triple treatment group were 63% (29/46) and 28.6% (4/14) (P = 0.033). Although a higher eradication rate was observed in CLA-resistant cases with sequential therapy, the difference did not reach statistical significance (P = 0.69). Conclusion In this study, standard triple treatment failed to eradicate H. pylori infection in the majority of the children, and sequential therapy offered only a small advantage over standard triple therapy in the eradication of CLA-resistant strains. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1202 / 1208
页数:7
相关论文
共 50 条
  • [21] Prevalence of clarithromycin-resistant H-pylori-strains in children:: Effect on therapy
    Jesch, I
    Kindermann, A
    Krauss-Etschmann, S
    Autenrieth, I
    Lehn, N
    Koletzko, S
    GUT, 1999, 45 : A93 - A93
  • [22] Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains
    Piana, A
    Are, BM
    Maida, I
    Dore, MP
    Sotgiu, G
    Realdi, G
    Mura, I
    MICROBIOLOGICA, 2002, 25 (02): : 123 - 130
  • [23] Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update
    Nyssen, Olga P.
    Martinez, Belen
    Megraud, Francis
    Savarino, Vincenzo
    Fallone, Carlo A.
    Bazzoli, Franco
    Gisbert, Javier P.
    ANTIBIOTICS-BASEL, 2024, 13 (02):
  • [24] Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study
    Hassan Seddik
    Samir Ahid
    Tarek El Adioui
    Fatim-Zohra El Hamdi
    Mohammed Hassar
    Redouane Abouqal
    Yahia Cherrah
    Ahmed Benkirane
    European Journal of Clinical Pharmacology, 2013, 69 : 1709 - 1715
  • [25] Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study
    Seddik, Hassan
    Ahid, Samir
    El Adioui, Tarek
    El Hamdi, Fatim-Zohra
    Hassar, Mohammed
    Abouqal, Redouane
    Cherrah, Yahia
    Benkirane, Ahmed
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (09) : 1709 - 1715
  • [26] Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
    Ji Young Chang
    Ki-Nam Shim
    Chung Hyun Tae
    Ko Eun Lee
    Jihyun Lee
    Kang Hoon Lee
    Chang Mo Moon
    Seong-Eun Kim
    Hye-Kyung Jung
    Sung-Ae Jung
    BMC Gastroenterology, 17
  • [27] Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
    Chang, Ji Young
    Shim, Ki-Nam
    Tae, Chung Hyun
    Lee, Ko Eun
    Lee, Jihyun
    Lee, Kang Hoon
    Moon, Chang Mo
    Kim, Seong-Eun
    Jung, Hye-Kyung
    Jung, Sung-Ae
    BMC GASTROENTEROLOGY, 2017, 17
  • [28] Triple therapy with ilaprazole,levofloxacin and clarithromycin for the eradication of Helicobacter pylori
    黄伟平
    China Medical Abstracts(Internal Medicine), 2014, 31 (03) : 141 - 141
  • [29] Triple therapy using ciprofloxacin for eradication of clarithromycin and metronidazole-resistant Helicobacter pylori
    Lamarque, D
    Tankovic, J
    Berrhouma, A
    Sevin, E
    Delchier, JC
    GUT, 1997, 41 : A52 - A52
  • [30] Triple therapy using ciprofloxacin for eradication of clarithromycin and metronidazole-resistant Helicobacter pylori
    Lamarque, D
    Tankovic, J
    Berrhouma, A
    Sevin, E
    Delchier, AJC
    GUT, 1997, 41 : A104 - A104